@ananyamalhotra.bsky.social
Reposted
#ProstateCancer screening: Committee says no to testing all men
Bernard Rachet tells the Standard recommendations show urgent need for effective test or screening strategy that doesn't generate large numbers of false positives & add to burden on #NHS.
www.standard.co.uk/news/science...
Bernard Rachet tells the Standard recommendations show urgent need for effective test or screening strategy that doesn't generate large numbers of false positives & add to burden on #NHS.
www.standard.co.uk/news/science...
Prostate cancer screening: Committee says no to testing all men
The UK National Screening Committee said there were more harms than benefits to using the PSA test for screening all men.
www.standard.co.uk
December 1, 2025 at 2:58 PM
#ProstateCancer screening: Committee says no to testing all men
Bernard Rachet tells the Standard recommendations show urgent need for effective test or screening strategy that doesn't generate large numbers of false positives & add to burden on #NHS.
www.standard.co.uk/news/science...
Bernard Rachet tells the Standard recommendations show urgent need for effective test or screening strategy that doesn't generate large numbers of false positives & add to burden on #NHS.
www.standard.co.uk/news/science...
Reposted
Could #AI revolutionise #cancer care?
This #WorldCancerDay, we’re highlighting a #GlobalTrial exploring if #AI could help more cancer patients access high-quality radiotherapy treatment & improve #HealthEquity.
More about Ajay Aggarwal & his team's work👇 bit.ly/4gHOZxT
This #WorldCancerDay, we’re highlighting a #GlobalTrial exploring if #AI could help more cancer patients access high-quality radiotherapy treatment & improve #HealthEquity.
More about Ajay Aggarwal & his team's work👇 bit.ly/4gHOZxT
February 4, 2025 at 11:16 AM
Could #AI revolutionise #cancer care?
This #WorldCancerDay, we’re highlighting a #GlobalTrial exploring if #AI could help more cancer patients access high-quality radiotherapy treatment & improve #HealthEquity.
More about Ajay Aggarwal & his team's work👇 bit.ly/4gHOZxT
This #WorldCancerDay, we’re highlighting a #GlobalTrial exploring if #AI could help more cancer patients access high-quality radiotherapy treatment & improve #HealthEquity.
More about Ajay Aggarwal & his team's work👇 bit.ly/4gHOZxT
Reposted
Awareness is 🔑 in cancer prevention.
Dr Belot highlights the need for inclusive awareness programs & accessible resources. #WorldCancerDay #UnitedByUnique
Dr Belot highlights the need for inclusive awareness programs & accessible resources. #WorldCancerDay #UnitedByUnique
February 4, 2025 at 1:07 PM
Awareness is 🔑 in cancer prevention.
Dr Belot highlights the need for inclusive awareness programs & accessible resources. #WorldCancerDay #UnitedByUnique
Dr Belot highlights the need for inclusive awareness programs & accessible resources. #WorldCancerDay #UnitedByUnique
Reposted
Cancer research should go beyond single risk factors!
Miguel calls for a holistic approach to truly understand and tackle the disease effectively.
#WorldCancerDay2025
Miguel calls for a holistic approach to truly understand and tackle the disease effectively.
#WorldCancerDay2025
February 4, 2025 at 4:57 PM
Cancer research should go beyond single risk factors!
Miguel calls for a holistic approach to truly understand and tackle the disease effectively.
#WorldCancerDay2025
Miguel calls for a holistic approach to truly understand and tackle the disease effectively.
#WorldCancerDay2025
Reposted
Still on #WorldCancerDay, our Honorary member, Laura Woods @newcastleuni.bsky.social highlights the need for standards, collaboration, & patient engagement to drive impactful cancer research outcomes.
February 4, 2025 at 3:05 PM
Still on #WorldCancerDay, our Honorary member, Laura Woods @newcastleuni.bsky.social highlights the need for standards, collaboration, & patient engagement to drive impactful cancer research outcomes.
Reposted
UK sees 20% drop in #cancer mortality but diagnoses still rising
Bernard Rachet explains that despite advances in cancer care in recent decades, survival gaps and #inequalities must be addressed to improve UK cancer outcomes. @icon-lshtm.bsky.social
www.lshtm.ac.uk/newsevents/n...
#PublicHealth
Bernard Rachet explains that despite advances in cancer care in recent decades, survival gaps and #inequalities must be addressed to improve UK cancer outcomes. @icon-lshtm.bsky.social
www.lshtm.ac.uk/newsevents/n...
#PublicHealth
June 6, 2025 at 10:08 AM
UK sees 20% drop in #cancer mortality but diagnoses still rising
Bernard Rachet explains that despite advances in cancer care in recent decades, survival gaps and #inequalities must be addressed to improve UK cancer outcomes. @icon-lshtm.bsky.social
www.lshtm.ac.uk/newsevents/n...
#PublicHealth
Bernard Rachet explains that despite advances in cancer care in recent decades, survival gaps and #inequalities must be addressed to improve UK cancer outcomes. @icon-lshtm.bsky.social
www.lshtm.ac.uk/newsevents/n...
#PublicHealth
Reposted
Last week, our Research Degree student Koki Shimizu attended the EHA Congress in Milan 🇮🇹🤝
He presented his poster on “Socioeconomic inequalities in acute myeloid leukaemia treatment in England 🏴 ”— shedding light on the impact of social factors in cancer care. 👏
He presented his poster on “Socioeconomic inequalities in acute myeloid leukaemia treatment in England 🏴 ”— shedding light on the impact of social factors in cancer care. 👏
June 19, 2025 at 3:56 PM
Last week, our Research Degree student Koki Shimizu attended the EHA Congress in Milan 🇮🇹🤝
He presented his poster on “Socioeconomic inequalities in acute myeloid leukaemia treatment in England 🏴 ”— shedding light on the impact of social factors in cancer care. 👏
He presented his poster on “Socioeconomic inequalities in acute myeloid leukaemia treatment in England 🏴 ”— shedding light on the impact of social factors in cancer care. 👏
Reposted
🚨New review led by @lshtm.bsky.social researchers @wendesafari.bsky.social & @camaringe.bsky.social, funded by @cancerresearchuk.org, reveals key missed opportunities in tackling cancer inequalities.
Most interventions focus narrowly on screening, missing broader systemic issues.
👉 bit.ly/44d1Tk8
Most interventions focus narrowly on screening, missing broader systemic issues.
👉 bit.ly/44d1Tk8
June 12, 2025 at 4:01 PM
🚨New review led by @lshtm.bsky.social researchers @wendesafari.bsky.social & @camaringe.bsky.social, funded by @cancerresearchuk.org, reveals key missed opportunities in tackling cancer inequalities.
Most interventions focus narrowly on screening, missing broader systemic issues.
👉 bit.ly/44d1Tk8
Most interventions focus narrowly on screening, missing broader systemic issues.
👉 bit.ly/44d1Tk8
Reposted
Lack of evidence on safety & effectiveness of physician associates & anaesthetic associates, review finds
@martinmckee.bsky.social discusses need for evidence-based strategy for expanding roles to address UK workforce shortages, & says patient safety is vital.
www.lshtm.ac.uk/newsevents/n...
@martinmckee.bsky.social discusses need for evidence-based strategy for expanding roles to address UK workforce shortages, & says patient safety is vital.
www.lshtm.ac.uk/newsevents/n...
March 10, 2025 at 10:39 AM
Lack of evidence on safety & effectiveness of physician associates & anaesthetic associates, review finds
@martinmckee.bsky.social discusses need for evidence-based strategy for expanding roles to address UK workforce shortages, & says patient safety is vital.
www.lshtm.ac.uk/newsevents/n...
@martinmckee.bsky.social discusses need for evidence-based strategy for expanding roles to address UK workforce shortages, & says patient safety is vital.
www.lshtm.ac.uk/newsevents/n...
Reposted
A recent @lshtm.bsky.social study led by Dr Ananya Malhotra examines how different immunotherapy treatments impact quality of life for advanced lung cancer patients over 18 months.
Findings highlight the need for a more personalised approach to care.
🔗 bit.ly/43FYPx5
Findings highlight the need for a more personalised approach to care.
🔗 bit.ly/43FYPx5
March 13, 2025 at 1:19 PM
A recent @lshtm.bsky.social study led by Dr Ananya Malhotra examines how different immunotherapy treatments impact quality of life for advanced lung cancer patients over 18 months.
Findings highlight the need for a more personalised approach to care.
🔗 bit.ly/43FYPx5
Findings highlight the need for a more personalised approach to care.
🔗 bit.ly/43FYPx5